Bostal is a technology-driven pharmaceutical company specializing in long-acting injectable (LAI) drug delivery solutions. Founded in New Jersey in 2004 by Ron Liu, Ph.D., MBA, Bostal has evolved into a global platform with the establishment of Bostal Drug Delivery (China) in 2013. Our clinical-stage pipeline is centered on transformative LAI therapies, including GLP-1 receptor agonists and treatments for schizophrenia.
We combine deep expertise in drug delivery science with full-spectrum execution capabilities — from early formulation to cGMP commercial manufacturing and U.S. market entry. Our integrated approach enables rapid advancement of high-barrier drug products through both the 505(b)(2) and ANDA regulatory pathways.
In 2009, Bostal acquired a 43,000 sq. ft. cGMP manufacturing and testing facility from Abbott Laboratories in Edison, New Jersey. Now serving as our U.S. headquarters, this FDA- and MHRA-audited site offers:
• Annual capacity of 2 billion solid oral dosage units
• cGMP suites for clinical supply and high-potency APIs
• Full DEA licensure (CII–CV) for controlled substance manufacturing
• Robust infrastructure for scale-up, exhibit, clinical, and commercial batch production
This facility anchors our global capability to take LAI products from lab to market with scientific precision and regulatory confidence.
In addition to development and manufacturing, Bostal actively markets and distributes finished pharmaceutical products across the U.S. Our portfolio includes generics and specialty drug products developed in-house or through strategic partnerships and acquisitions. With a strong network and reliable infrastructure, we deliver quality, affordability, and accessibility across all market segments.
mission & vision
At Bostal, we are committed to developing, manufacturing, and supplying high-quality, cost-effective pharmaceutical products that improve lives worldwide. Through innovation and partnership, we aim to become a globally recognized leader in long-acting drug delivery.
01 Team & Culture
We build top-tier teams in R&D, manufacturing, and commercialization, fostering a high-performance, collaborative work environment.
02 Scientific Leadership
We invest in platform innovation and proprietary technologies to maintain leadership in drug delivery and dosage form science.
03 Product Innovation & Partnerships
We co-develop high-barrier generics and novel therapies through strategic alliances, targeting growth in the U.S. and global markets.
04 Regulatory Excellence & Sustainability
We maintain full compliance with global cGMP standards, drive continuous quality improvement, support academic collaborations, and uphold environmental responsibility.